Tina Marriott, President and COO of Recursion Pharmaceuticals, completed a sale of 14,319 shares of the company's Class A Common Stock on August 15, 2024. The shares were sold at a price of $6.69 per share, resulting in a total transaction value of $95,794.11. Following the transaction, Marriott's direct holdings in Recursion Pharmaceuticals amount to 521,138 shares. The sale was conducted under a transaction code indicating the payment of exercise price or tax liability by delivering or withholding securities.

Tina Marriott, President and COO of Recursion Pharmaceuticals, completed a sale of 14,319 shares of the company's Class A Common Stock on August 15, 2024. The shares were sold at a price of $6.69 per share, resulting in a total transaction value of $95,794.11. Following the transaction, Marriott's direct holdings in Recursion Pharmaceuticals amount to 521,138 shares. The sale was conducted under a transaction code indicating the payment of exercise price or tax liability by delivering or withholding securities.